Is nephrogenic systemic fibrosis linked to the introduction of contrast-enhanced MR angiography?
Gossner
Johannes
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002614:Chelating Agents; D015897:Comorbidity; D005682:Gadolinium; D006801:Humans; D015994:Incidence; D008279:Magnetic Resonance Imaging / Q000706:statistics & numerical data*; D008875:Middle Aged; D009518:New York / Q000453:epidemiology; D051437:Renal Insufficiency / Q000453:epidemiology*; D012189:Retrospective Studies; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D012595:Scleroderma, Systemic / Q000453:epidemiology*; D013577:Syndrome
D002614:Chelating Agents; D005682:Gadolinium